Ortho Clinical Diagnostics Holdings plc Receivables

The latest receivables for OCDX is $240M as of April 2022. That compares with $320M in the prior-year period — down 25.6% year over year. Investors often review this figure alongside Ortho Clinical Diagnostics Holdings plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, OCDX's receivables moved from $320M to $240M — a 25.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ortho Clinical Diagnostics Holdings plc's operating scale or balance-sheet position.

A receivables figure of $240M for OCDX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting OCDX's receivables ($240M), review year-over-year change from $320M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Ortho Clinical Diagnostics Holdings plc's receivables against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.